These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33000327)

  • 1. Development and content validation of the Pediatric Oral Medicines Acceptability Questionnaires (P-OMAQ): patient-reported and caregiver-reported outcome measures.
    Turner-Bowker DM; An Haack K; Krohe M; Yaworsky A; Vivas N; Kelly M; Chatterjee G; Chaston E; Mann E; Reaney M
    J Patient Rep Outcomes; 2020 Oct; 4(1):80. PubMed ID: 33000327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing asthma symptoms in children: qualitative research supporting the development of the Pediatric Asthma Diary-Child (PAD-C) and Pediatric Asthma Diary-Observer (PAD-O).
    Bradley H; Trennery C; Jones AM; Lydon A; White F; Williams-Hall R; Arbuckle R; Tomaszewski E; Shih VH; Haughney J; Eisen A; Winders T; Coons SJ; Eremenco S;
    J Patient Rep Outcomes; 2023 Oct; 7(1):104. PubMed ID: 37863864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Psychometric Evaluation of the Life Interference Questionnaire for Growth Hormone Deficiency (LIQ-GHD) to Assess Growth Hormone Injection Burden in Children and Adults.
    Turner-Bowker DM; Yaworsky A; Palladino A; Lamoureux RE; Kelly M; Love E; Pleil AM; Shields A; Loftus J
    Patient; 2020 Jun; 13(3):289-306. PubMed ID: 31956960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of the Patient- and Observer-Reported PRUCISION Instruments to Assess Pruritus and Sleep Disturbance in Pediatric Patients with Cholestatic Liver Diseases.
    Gwaltney C; Bean S; Venerus M; Karlsson L; Warholic N; Kjems L; Horn P
    Adv Ther; 2022 Nov; 39(11):5126-5143. PubMed ID: 36066744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key measurement concepts and appropriate clinical outcome assessments in pediatric achondroplasia clinical trials.
    Aldhouse NVJ; Kitchen H; Johnson C; Marshall C; Pegram H; Pease S; Collins S; Baker CL; Beaverson K; Crews C; Massey J; Wyrwich KW
    Orphanet J Rare Dis; 2022 May; 17(1):182. PubMed ID: 35525989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Questionnaires for Assessing Signs and Symptoms of Eosinophilic Esophagitis in Children.
    Kamat S; Yaworsky A; Guillemin I; Krohe M; Litcher-Kelly L; McLafferty M; Lamoureux RE; Lowe C; Chehade M; Spergel JM; Weinfurt K; Turner-Bowker DM
    J Allergy Clin Immunol Pract; 2022 Jul; 10(7):1856-1863.e3. PubMed ID: 35398552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative Development and Content Validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument.
    McCarrier KP; Atkinson TM; DeBusk KP; Liepa AM; Scanlon M; Coons SJ;
    Clin Ther; 2016 Apr; 38(4):794-810. PubMed ID: 27041408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Acceptability and Preferences for Solid Oral Dosage Form Drug Product Attributes: A Scoping Review.
    Hauber B; Hand MV; Hancock BC; Zarrella J; Harding L; Ogden-Barker M; Antipas AS; Watt SJ
    Patient Prefer Adherence; 2024; 18():1281-1297. PubMed ID: 38919378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and content validity testing of patient-reported outcome (PRO) items to assess chest congestion associated with the common cold for use in children and adolescents.
    Arbuckle R; Marshall C; Grant L; Burrows K; Albrecht HH; Shea T
    J Patient Rep Outcomes; 2022 May; 6(1):56. PubMed ID: 35633410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Focal Segmental Glomerulosclerosis Patient-Reported Outcome Measures: Symptom Diary and Symptom Impact Questionnaire.
    Mathias SD; Vallow S; Gipson DS; Thorneloe KS; Sprecher D
    Am J Kidney Dis; 2017 Oct; 70(4):532-540. PubMed ID: 28663063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Caregiver Burden Questionnaire for Heart Failure (CBQ-HF): face and content validity.
    Humphrey L; Kulich K; Deschaseaux C; Blackburn S; Maguire L; Strömberg A
    Health Qual Life Outcomes; 2013 May; 11():84. PubMed ID: 23706131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and initial testing of a new instrument to measure the experience of eczema control in adults and children: Recap of atopic eczema (RECAP).
    Howells LM; Chalmers JR; Gran S; Ahmed A; Apfelbacher C; Burton T; Howie L; Lawton S; Ridd MJ; Rogers NK; Sears AV; Spuls P; von Kobyletzki L; Thomas KS
    Br J Dermatol; 2020 Sep; 183(3):524-536. PubMed ID: 31794074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing Angelman syndrome-specific clinician-reported and caregiver-reported measures to support holistic, patient-centered drug development.
    Connor-Ahmad S; Tjeertes J; Chladek M; Newton L; Symonds T; Clinch S; Vincenzi B; McDougall F
    Orphanet J Rare Dis; 2023 Jun; 18(1):156. PubMed ID: 37349793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of patient- and observer-reported outcome measures to assess COVID-19 signs and symptoms in children and adolescents.
    Romano C; Mayorga M; Ruiz-Guiñazú J; Trudel GC; Fehnel S; McQuarrie K; Chan EKH; Katz EG
    J Patient Rep Outcomes; 2023 Jan; 7(1):7. PubMed ID: 36701073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the PROFAD-SSI-SF in Patients with Primary Sjögren's Syndrome with Organ Involvement: Results of Qualitative Interviews and Psychometric Analyses.
    Raymond K; Maher S; Saucier CD; O'Connor M; Yarlas A; Kosinski M; Chen WH; Gairy K
    Rheumatol Ther; 2023 Feb; 10(1):95-115. PubMed ID: 36227531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Clinical Global Impression of Change (CGI-C) and a Caregiver Global Impression of Change (CaGI-C) measure for ambulant individuals with Duchenne muscular dystrophy.
    Staunton H; Trennery C; Arbuckle R; Guridi M; Zhuravleva E; Furlong P; Fischer R; Hall R
    Health Qual Life Outcomes; 2021 Jul; 19(1):184. PubMed ID: 34311756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a patient-reported outcome (PRO) measure to assess patient perceptions of simplicity and complexity of treatment for type 2 diabetes.
    Stewart KD; Matza LS; Patel H; Boye KS
    J Patient Rep Outcomes; 2023 Sep; 7(1):89. PubMed ID: 37672123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative exploration of the visual function impairments and impacts on vision-dependent activities of daily living in Retinitis Pigmentosa and Leber Congenital Amaurosis: content validation of the ViSIO-PRO and ViSIO-ObsRO measures.
    Kay C; Audo I; Naujoks C; Spera C; Fischer MD; Green J; Durham T; Williamson N; Bradley H; Barclay M; Sims J; Banhazi J; Patalano F
    J Patient Rep Outcomes; 2023 Jul; 7(1):74. PubMed ID: 37466759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Conceptual Model of Angelman Syndrome and Review of Relevant Clinical Outcomes Assessments (COAs).
    Grieco JC; Romero B; Flood E; Cabo R; Visootsak J
    Patient; 2019 Feb; 12(1):97-112. PubMed ID: 29987743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.